Search Records

Health Canada has adopted and integrated the use of risk management plans (RMPs) and the International Conference on Harmonization (ICH) E2E Guideline into the regulatory review of drugs in Canada. A risk management plan (RMP) is a document that identifies and characterizes risks and...

Information on risk management plan submissions for drugs including when to file, considerations, requirements, and compliance.

Opioid products need to include specific content within their RMP to address: the risk and uncertainties of opioid-related harms in Canada and other risks and uncertainties posed by the product, where warranted.

The RMP summary should include specific sections, which mirror the EU RMP Summary format sections.

A Canadian-specific addendum should address: risks or uncertainties that are unique to the Canadian context, and measures that the manufacturer intends to take that are unique to the Canadian context.

Opioids are medications that are usually prescribed to treat pain. When taken properly, prescription opioids can help patients experiencing pain manage their conditions, allowing them to lead full and productive lives. However, as with all medications, opioids can come with risks and potentially...

This biosafety advisory is being provided by the Public Health Agency of Canada (PHAC) to assist clinical, diagnostic, and research laboratories in implementing proper biosafety procedures to safely handle samples that may contain SARS-CoV-2. This biosafety advisory also aims to support local...

How to care at home for someone who has or may have been exposed to COVID-19.

Don't want to drink? Want to reduce possible risks? This is the Drinking is up to you (poster).

The Infectious Disease and Climate Change Fund (IDCCF) addresses the impact of climate change on human health in Canada by: increasing capacity, enabling Canadians and communities and improving adaptability and resiliency.